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Abstract
Fungal infections of the central nervous system are an uncommon cause of rapid decline in
consciousness. We describe the case of central nervous system aspergillosis in a patient on
immunosupressants whose clinical course highlights the need for an aggressive approach to diagnosis.
Case presentation
A 53-year-old right-handed Caucasian woman with a
history of Crohn’s disease for four decades presented with
pneumonia and a change in mental status. She was taking
prednisone daily for a recent Crohn’s exacerbation.
Methotrexate was added 2 weeks prior. On physical
examination, she had hypotension, tachycardia and
thrombocytopenia. She was comatose and responses to
painful stimuli were decreased on left side. A CT scan of
the brain showed multiple areas of hypodensity. A brain
MRI (Figure 1) showed numerous foci of T1 hypointensity
and T2 hyperintensity in the periventricular, subcortical
and deep white matter, including the gray-white junction.
There were also lesions in the basal ganglia, thalami, pons
and cerebellum that showed diffusion restriction. The
distribution and properties of these radiological images
were suggestive of septic emboli. She had an extensive left
upper lobe consolidation on chest X-Ray. Bronchoscopy
revealed aspergillus, which lead to a diagnosis of CNS
aspergillosis. Despite antifungal therapy she succumbed to
her disease and the decision was made to withdraw care in
light of her poor neurological status.
Discussion
Aspergillus is a saprophytic, opportunistic fungus that can
infect humans, especially immunocompromised hosts [1].
The primary portal of entry for aspergillus is therespiratory
tract. From there, it secondarily infects the brain via
hematogenous spread. In some cases, it can also result
from penetrating trauma or extension of infection from
the mastoid air sinuses [2].
CNS aspergillosis should be considered in patients
presenting with the acute onset of focal neurologic deficits,
especially in immunocompromised hosts. The most
frequent symptoms are headache, vomiting, convulsion,
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(page number not for citation purposes)hemiparesis, fever, cranial nerve deficits, paralysis and
sensory impairment of varying degrees. Since aspergillus
can form mycotic aneurysms, it can lead to subarachnoid
hemorrhage and meningeal signs. The propensity of the
fungus to invade blood vessels may lead to extensive
necrosis or intracranial bleeding [3].
The MRI in CNS aspergillosis typically shows infarction or
abscesses in multiple brain areas, including the basal
ganglia and thalami [4]. Although the mortality rate in
CNS aspergillosis approaches 95% [5], recent reports
suggest that early initiation of antifungal therapy with
neurosurgical intervention can improve outcomes [6].
List of abbreviations
CT, Computerized tomography; CNS, Central nervous
system; MRI, Magnetic resonance imaging.
Consent
Written informed consent was obtained from the patient’s
family for publication of this case report and accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS was a major contributor in writing the manuscript and
performing the literature review. PS contributed to writing
the manuscript and performing the literature review. HS
performed the clinical examination of the patient and
interpreted the patient data. WY interpreted radiological
studies. PES analyzed and interpreted the patient data and
edited the manuscript. All authors read and approved the
final manuscript.
References
1. Nadkarni T, Goel A: Aspergilloma of the brain: an overview.
J Postgrad Med 2005, 51:S37-S41.
2. Marinovic T, Skrlin J, Vilendecic M, Rotim K, Grahovac G: Multiple
aspergillus brain abscesses in immuno-competent patient
with sever cranio-facial trauma. Acta Neurochir (Wien) 2007,
149:629-632.
3. Sharma RR, Lad SD, Desai AP, Lynch PG: Surgical Management of
Fungal Infections of the Nervous System. In Operative
Neurosurgical Techniques: Indications, Methods and Results. 4
th edition.
Edited by Schmidek and Sweet. Philadelphia: WB Saunders Company;
2000:1726-1755.
4. DeLone DR, Goldstein RA, Petermann G, Salamat MS, Miles JM,
Knechtle SJ et al.: Disseminated aspergillosis involving the
brain: distribution and imaging characteristics. Am J Neuroradiol
1999, 20:1597-1604.
5. Patterson TF: Aspergillus species. In Principles and Practice of
Infectious Diseases. 6
th edition. Edited by Mandell GL, Bennett JE and
Dolin R. Philadelphila, PA: Churchill Livingstone; 2005:2958-2972.
6. Schwartz S, Ruhnke M, Ribaud P, Corey L, Driscoll T, Cornely OA
et al.: Improved outcome in central nervous system
aspergillosis using voriconazole treatment. Blood 2005,
106:2641-2645.
Figure 1. Axial MR images demonstrating diffusion restriction
(A & B), hyperintensities on FLAIR images (C), and
hypointensities on T1 images (D).
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